VIP FAQ for Laboratory Researchers
This comprehensive VIP FAQ provides principal investigators, laboratory managers, and biochemical researchers with technical specifications regarding Vasoactive Intestinal Peptide. Explore details on molecular structure, receptor affinity, analytical purity standards, reconstitution protocols, and procurement protocols for strictly non-clinical investigation.
Quick answer
This comprehensive VIP FAQ provides principal investigators, laboratory managers, and biochemical researchers with technical specifications regarding Vasoactive Intestinal Peptide. Explore details on molecular structure, receptor affinity, analytical purity standards, reconstitution protocols, and procurement protocols for strictly non-clinical investigation.
Key takeaways
- Vasoactive Intestinal Peptide (VIP) is a basic 28-amino acid neuropeptide belonging to the glucagon/secretin superfamily.
- In vitro signaling assays demonstrate that VIP acts as a high-affinity agonist at two distinct Class B G-protein coupled receptors: VPAC1 and VPAC2.
- Maintaining chemical integrity across experimental replicates requires rigorous quality verification.
- In cell culture and preclinical tissue studies, bacterial endotoxin contamination—specifically lipopolysaccharides (LPS)—can introduce unwanted immunological noise, confound cytokine expression assays, and invalidate experimental outcomes.
Biochemical Profile and Structure of Vasoactive Intestinal Peptide
Vasoactive Intestinal Peptide (VIP) is a basic 28-amino acid neuropeptide belonging to the glucagon/secretin superfamily. Originally isolated from porcine intestinal tissue, VIP exhibits a conserved primary sequence across mammalian species, featuring a C-terminal alpha-amide group essential for full biological potency in cell culture models. In preclinical literature, researchers classify VIP as a primary regulatory peptide operating across the central nervous system, gastrointestinal tract, and immune microenvironments.
When evaluating VIP for laboratory research, investigators study its spatial conformation, which shifts from a random coil in aqueous solution to an amphipathic alpha-helix upon interacting with membrane phospholipids or specific receptor binding pockets. Understanding these structural dynamics is critical when designing in vitro assays or assessing peptide-receptor binding dynamics in academic and commercial laboratories. For a broader overview of comparative signaling molecules, consult our complete research library hub.
Receptor Affinity and Downstream Signaling Pathways
In vitro signaling assays demonstrate that VIP acts as a high-affinity agonist at two distinct Class B G-protein coupled receptors: VPAC1 and VPAC2. Additionally, VIP exhibits lower-affinity interactions with the peptide receptor PAC1. Both VPAC1 and VPAC2 couple primarily to the Gs alpha subunit, activating adenylyl cyclase and triggering downstream intracellular cyclic adenosine monophosphate (cAMP) accumulation and protein kinase A (PKA) phosphorylation cascades.
Preclinical models indicate that VIP signaling influences diverse cellular pathways, including nuclear factor kappa B (NF-kB) down-regulation, mitogen-activated protein kinase (MAPK) modulation, and cytokine transcription suppression in isolated macrophage and dendritic cell cultures. Animal research models further reveal that local VIP administration modulates vascular tone, smooth muscle relaxation, and epithelial chloride secretion. Investigators studying these pathways frequently cross-reference data from PACAP-38 research peptides to delineate VPAC-selective versus PAC1-selective mechanism responses.
Analytical Purity Verification: HPLC and Mass Spectrometry
Maintaining chemical integrity across experimental replicates requires rigorous quality verification. Every batch of synthetic VIP supplied by PX1 Research undergoes rigorous High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) testing in an ISO 17025 accredited analytical facility to ensure a minimum purity threshold of 98%.
HPLC chromatograms provide visual and quantitative confirmation of peptide purity by measuring peak area percentage, ensuring the absence of truncated sequences, deletion peptides, or residual protecting groups. Mass spectrometry confirms the exact molecular weight (3325.8 Da theoretical) to verify sequence fidelity. Each shipment includes a lot-specific Certificate of Analysis (COA) detailing these metrics, providing researchers with complete transparency before initiating cellular assays or preclinical models.
Endotoxin Limits and Quality Assurance Standards
In cell culture and preclinical tissue studies, bacterial endotoxin contamination—specifically lipopolysaccharides (LPS)—can introduce unwanted immunological noise, confound cytokine expression assays, and invalidate experimental outcomes. To mitigate these risks, PX1 Research enforces strict endotoxin screening protocols utilizing Kinetic Chromogenic Limulus Amebocyte Lysate (LAL) testing.
All VIP batches are validated to contain endotoxin levels well below industry thresholds (typically <0.01 EU/mg). Manufactured in USA-based, GMP-compliant facilities, our synthesis workflows adhere to stringent environmental and chemical standards. This rigorous control guarantees that observed immune or vascular responses in your research are attributable solely to the VIP peptide sequence and not exogenous contaminants.
Reconstitution Protocols and Solvent Selection for In Vitro Use
Lyophilized VIP is supplied as a sterile, vacuum-sealed trifluoroacetate (TFA) salt cake. Proper reconstitution protocols are critical to maintain secondary structure and prevent aggregation. For standard laboratory applications, reconstitute the lyophilized powder in sterile, deionized laboratory-grade water or bacteriostatic water to a target stock concentration between 1.0 mg/mL and 5.0 mg/mL.
If buffer conditions require neutral pH solutions, such as Phosphate-Buffered Saline (PBS), researchers should first dissolve the peptide cake in a minimal volume of sterile water or dilute acetic acid (0.1%) before diluting into PBS. Direct addition of high-ionic-strength neutral buffers to dry lyophilized peptide can induce localized aggregation or incomplete dissolution. After complete solubilization, aliquot the stock solution into single-use polypropylene microtubes to eliminate freeze-thaw degradation cycles during ongoing experimentation.
Storage, Handling, and Thermal Stability Parameters
Lyophilized VIP exhibits robust stability when stored under controlled environment conditions. For short-term transit, dry lyophilized vials remain stable at ambient temperatures; however, long-term laboratory storage requires desiccated placement at -20°C or -80°C, where the peptide remains stable for up to 24 months from the date of synthesis.
Once reconstituted into aqueous solution, peptide stability decreases over time. Stock aliquots stored at 4°C should be utilized within 3 to 7 days. For extended studies, reconstituted stock solutions stored at -80°C maintain analytical integrity for 3 to 6 months, provided repeated thermal cycling is strictly avoided. Light exposure should be minimized during storage and handling to prevent photo-oxidation of methionine and tryptophan residues present in the sequence.
Comparative Analysis: VIP vs. Related Secretin-Family Peptides
When designing comparative neuropeptide or secretin-superfamily studies, researchers frequently evaluate VIP alongside structurally homological analogs. The primary comparative compounds in this class include PACAP-38, Secretin, and GHRH research peptides. While sharing significant sequence homology and a conserved N-terminal region, these peptides demonstrate distinct receptor binding profiles and downstream physiological activity in preclinical models.
For instance, while VIP binds VPAC1 and VPAC2 with equivalent sub-nanomolar affinity, PACAP-38 displays high affinity for the PAC1 receptor in addition to VPAC1/VPAC2, making it a valuable tool for isolating PAC1-mediated neuronal signaling. Secretin preferentially targets the Secretin Receptor (SCTR) with minimal cross-reactivity at VPAC receptors. Meanwhile, GHRH exhibits restricted selectivity toward the GHRH receptor, primarily influencing somatotroph activity rather than systemic immune microenvironments. Understanding these affinity gradients allows principal investigators to select the exact control peptides required for complex receptor-binding cross-talk studies.
Preclinical Research Applications and In Vitro Assays
In academic and pharmaceutical research, VIP is widely investigated for its neuroprotective, anti-inflammatory, and immunomodulatory mechanisms. In vitro experiments using primary microglial cultures indicate that VIP application down-regulates pro-inflammatory mediator production, including TNF-alpha, IL-6, and inducible nitric oxide synthase (iNOS), following lipopolysaccharide challenge.
Rodent research models exploring gastrointestinal barrier function have evaluated VIP's role in maintaining tight junction integrity and modulating mucosal dendritic cell maturation. Furthermore, isolated vascular tissue preparations demonstrate VIP-mediated vasodilation via endothelium-independent smooth muscle hyperpolarization. For researchers conducting parallel tissue regeneration or cytoprotective studies, VIP is frequently studied alongside tissue remodeling peptides such as BPC-157 peptides and Thymosin Beta-4.
Procurement and Laboratory Account Logistics
PX1 Research streamlines peptide procurement for academic institutions, biotechnology firms, and contract research organizations (CROs). We offer direct online ordering for single-vial evaluation as well as specialized institution account features for high-volume, ongoing projects. Qualified procurement departments can access bulk pricing structures and dedicated supply agreements via our wholesale laboratory accounts portal.
Orders are fulfilled directly from our domestic, USA-based facilities in California and Arizona. Standard orders received Monday through Friday prior to 2:00 PM PST are processed and shipped same-day via expedited courier services to maintain cold-chain integrity and eliminate supply chain delays in ongoing research projects.
Frequently Asked Questions
What is the primary target of VIP in laboratory research?
Vasoactive Intestinal Peptide (VIP) functions as a high-affinity agonist at the VPAC1 and VPAC2 G-protein coupled receptors, activating adenylyl cyclase and cAMP-dependent signaling cascades in cellular models.
How is VIP purity verified by PX1 Research?
Every lot of synthetic VIP undergoes high-performance liquid chromatography (HPLC) and mass spectrometry (MS) at an ISO 17025 accredited laboratory to verify sequence identity and confirm a minimum purity threshold of 98%.
What endotoxin control measures are applied to VIP batches?
PX1 Research subjects all VIP batches to Kinetic Chromogenic LAL testing, ensuring endotoxin levels remain below strictly monitored research thresholds (<0.01 EU/mg) to prevent immune cell assay interference.
What solvent is recommended for reconstituting lyophilized VIP?
Lyophilized VIP should be reconstituted using sterile deionized laboratory-grade water or bacteriostatic water to form a stable stock solution prior to dilution into culture media or saline buffers.
How should reconstituted VIP solutions be stored in the lab?
Reconstituted stock solutions should be divided into single-use aliquots and stored at -80°C for long-term stability (3–6 months) or kept at 4°C for short-term use (up to 7 days), avoiding freeze-thaw cycles.
What is the molecular weight and sequence length of VIP?
VIP is a 28-amino acid neuropeptide with a molecular weight of approximately 3325.8 Da and a C-terminal alpha-amide modification essential for receptor activation.
Which related peptides are typically compared with VIP in signaling studies?
Researchers frequently compare VIP against PACAP-38, Secretin, and GHRH to delineate selective binding actions across the Class B GPCR neuropeptide family.
Does PX1 Research provide a Certificate of Analysis (COA) with VIP orders?
Yes. Every shipment of VIP includes a lot-specific Certificate of Analysis detailing HPLC purity percentage, mass spectrometry verification, and endotoxin assay results.
Where is PX1 Research VIP synthesized and shipped from?
PX1 Research peptides are USA-synthesized in GMP-compliant facilities and shipped directly from our distribution centers located in California and Arizona.
Is VIP supplied by PX1 Research suitable for human administration?
No. VIP supplied by PX1 Research is strictly designated as a research-grade chemical compound intended solely for in vitro laboratory experimentation and preclinical scientific research. It is not for human or veterinary use.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.